Skip to content
★ Sign in to follow
KT

Kristina Torfgård

IRLAB Theraoeutics AB
Total declarations
3
Company
1
▲ Purchases (2 ops.)
€18k
▼ Sales (0 ops.)
—

Latest filing published 27 Jul 2025 for IRLAB Theraoeutics AB, €24k.

Filing timeline

BuySale
Kristina Torfgård

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

Closed purchases

Market purchases
2

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Kristina Torfgård: trading record in brief

All filings by Kristina Torfgård on record concern IRLAB Theraoeutics AB. In total, 3 filings cover trades dated from 5 August 2024 to 24 July 2025.

Every open-market trade on record is a purchase: 2 purchases worth €18k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.

The latest filing, published on 27 July 2025, reports a transaction of €24k in IRLAB Theraoeutics AB. The last purchase on record was published on 5 August 2024, which is 825 days ago. The median gap between trade and publication is zero days: most filings appear on the same day. Under the Market Abuse Regulation, managers have three business days to notify their trades. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.

Companies and markets linked to Kristina Torfgård

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations3 total
  • ●
    Verkställande direktör (VD)ExecutivesIRLAB Theraoeutics AB
    264,562 SEK0FI-SE
    75,589 shares@ SEK 3.50BTA (betald tecknad aktie)ISIN SE0025400179FI:csv-709879d26a5cbd9b99f2
  • ▲
    Verkställande direktör (VD)ExecutivesIRLAB Theraoeutics AB
    140,850 SEK29FI-SE
    9,000 shares@ SEK 15.6566.5% of flowAktieISIN SE0012675361FI:csv-a982029ec0819cae0a63
    Canonical exit: 3 Nov 2024 (T+90)
  • ▲
    Verkställande direktör (VD)ExecutivesIRLAB Theraoeutics AB
    70,875 SEK25FI-SE
    4,500 shares@ SEK 15.7533.5% of flowAktieISIN SE0012675361FI:csv-aea65347837e98c9cdbf
    Canonical exit: 3 Nov 2024 (T+90)

3 of 3 declarations